This site contains promotional information intended only for healthcare professionals resident in the United Kingdom

Visit Pfizer Medical site

Menu

Close

Sign InLog Out
  • EN
Single LinkDropdownLabelLinkLinkLinkLinkLinked DropdownLabelLinkLinkLinkLinkMega MenuHeading

Example of description text sitting alongside header

LabelLinkLinkLinkLinkLabelLinkLinkLinkLinkLabelLinkLinkLinkLink
Linked Mega MenuHeading

Example of description text sitting alongside header

LabelLinkLinkLinkLinkLabelLinkLinkLinkLinkLabelLinkLinkLinkLink
EN - EnglishSelect a languageLanguagesEN - EnglishFR - Françias

Menu

Close

Sign InLog Out
  • EN
Single LinkDropdownLabelLinkLinkLinkLinkLinked DropdownLabelLinkLinkLinkLinkMega MenuHeading

Example of description text sitting alongside header

LabelLinkLinkLinkLinkLabelLinkLinkLinkLinkLabelLinkLinkLinkLink
Linked Mega MenuHeading

Example of description text sitting alongside header

LabelLinkLinkLinkLinkLabelLinkLinkLinkLinkLabelLinkLinkLinkLink
EN - EnglishSelect a languageLanguagesEN - EnglishFR - Françias
Search

Menu

Close

Sign In or RegisterLog Out
Pfizer MedicinesTherapy AreasExplore ContentEventsVideosMaterialsFeatured ArticlesLet’s ConnectSupplyAlliance HealthcareOff-contract claims

Adverse event reporting can be found at the bottom of the page

Menu

Close

AMSAMSAn introduction to antimicrobial stewardshipStewardshipSurveillanceRace against resistanceABSABSABS in practice Educational ResourcesAFSAFSShape the futureAFS in practiceImplementing an AFS programmeDiagnosticsGuidelinesCase studiesAll case studiesOur CommitmentOur CommitmentOur commitment to anti-infectivesHeritageSustainability
Our work in the community
Support & ResourcesSupport & ResourcesVideosMaterialsOnline LearningOnline LearningHomeINSPIRE To: Change the CourseThe global threat of carbapenemase-producing enterobacterales (CPE)CPE Epidemiology CPE Factsheet London AMS SeriesNorth West England AMS SeriesInfectious Thinking Podcasts

Information on how to access prescribing information and adverse event reporting can be found at the bottom of the page.

Educational Resources

Antimicrobial Stewardship Toolkit

National AMS Guidance

On-Demand Webinars

The AMS Toolkit contains a variety of resources aimed to offer tips and advice to HCPs looking to implement and maintain an AMS programme within the secondary healthcare setting. Hear from Dr Matt Laundy, Consultant Microbiologist, explain how the toolkit could support AMS implementation at your trust. 

AMS Toolkit Resource

Click on the cards below to download the resources AMS Lead Resource Pack - 'At a Glance'

Leading an AMS programme is a multi-faceted process requiring a coordinated response that engages colleagues and supports their active involvement. The items within this pack are designed to help you and your AMS Champions deliver excellent and consistent patient care through collaboration between all members of the hospital team.

Download Loading
AMS Champion Resource Pack - 'At a Glance'

As an AMS Champion you play a key role in engaging with colleagues and supporting their active involvement with Antimicrobial Stewardship. The items within this pack are designed to help AMS Champions develop excellent and consistent patient care through collaboration with all members of the hospital team.

Download Loading
Individual Guides Nurse Guide

Educational poster/leaflet for nurses to support them in their role in antimicrobial stewardship.

Download Loading
NICE Guidance Summary

A short summary of things to implement in your department.
 

Download Loading
Lead Guide

A guide for a clinical lead to implement an antimicrobial stewardship programme in their clinical setting. Leading an AMS programme is a multi-faceted process requiring a coordinated response that engages colleagues and supports their active involvement. The items within this pack are designed to help you and your AMS Champions deliver enhanced and consistent patient care through collaboration between all members of the hospital team.

Download Loading
Champion Guide

A guide for AMS Champions to implement an antimicrobial stewardship programme in their local clinical setting as directed by the programme lead. Please note this content is suggestive and not directive.

Download Loading
Poster Resources AMS Awareness Poster (HCP) Download Loading Start Smart then Focus Poster Download Loading

Prescribing Information

National Policies on AMS/AMR

UK's 5-year national action plan

Contained and controlled:

UK's 20-year vision for antimicrobial resistance

Public Health England (PHE):

Infectious diseases strategy 2020 to 2025

The Association of the British Pharmaceutical Industry (ABPI) Industry Examples:

Fighting back: How pharmaceutical companies are stepping up in the war against antimicrobial resistance

Guidance for Primary and Secondary Care AMS:PHE Start Smart then Focus:

Antimicrobial stewardship toolkit for English hospitals

Secondary, primary and community care. NICE AMS library of guidance:

NICE library of antibiotic prescribing guidelines
Healthcare-associated infections

British Society for Antimicrobial Chemotherapy (BSAC):

Journal of Antimicrobial Chemotherapy - Antimicrobial Resistance (BSAC JAC).

Royal College of General Practitioners (RCGP):

TARGET Antibiotics Toolkit

Prescribing information

Click here for Zavicefta (avibactam sodium, ceftazidime pentahydrate) Prescribing Information

Click here for CRESEMBA® (isavuconazole) Prescribing Information

PP-CRB-GBR-2096. September 2023

Click here for ZAVICEFTA® (avibactam sodium, ceftazidime pentahydrate) prescribing information

Click here for CRESEMBA® (isavuconazole) prescribing information

Zavicefta Visit site Loading Antifungal Stewardship resources Visit site Loading
PP-CRB-GBR-2096. September 2023

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search 

for MHRA Yellow Card in Google Play or Apple App Store

 

Adverse events should also be reported to Pfizer Medical Information on 01304 616161

PfizerPro Account

To access further materials, resources and receive communication about medicines and vaccines promoted by Pfizer.

Sign In or RegisterAccountSign Out

This site is intended only for healthcare professionals resident in the United Kingdom. If you are a member of the public wishing to access information on a specific medicine, please visit www.medicines.org.uk/emc

 

This website is brought to you by Pfizer Limited, a company registered in England 

and Wales under No. 526209 with its registered office at Ramsgate Road, Sandwich, Kent, CT13 9NJ

 

Copyright © 2024 Pfizer Limited. All rights reserved.

 

VAT registration number GB201048427

PP-UNP-GBR-7866. January 2024
For UK Healthcare Professionals*

These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.

I confirm that I am a healthcare professional* resident in the United Kingdom.

If you select 'No', you will be redirected to Pfizer.co.uk where you will be able to access reference information on Pfizer's prescription medicines.

*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.

PP-UNP-GBR-7812. January 2024

YesNo
You are now leaving PfizerPro​​​​​

​​​​​​​You are now leaving www.pfizerpro.co.uk. Links to external websites are provided as a resource to the viewer. This website is neither owned or controlled by Pfizer Ltd. 

Pfizer accepts no responsibility for the content or services of the linked site.​​​​​​​​​​​​​​

​​​​​​​PP-PFE-GBR-3858. November 2021​​​​​​​
​​​​​​​
You are now leaving PfizerPro
​​​​​​​
​​​​​​​You are now leaving www.pfizerpro.co.uk. Links to external websites are provided as a resource to the viewer. This website is neither owned nor controlled by Pfizer Ltd. 

Pfizer accepts no responsibility for the content or services of the linked site other than the information or other materials relating to ​​​​​Pfizer medicines or 
business which it has provided or reviewed.

PP-PFE-GBR-3859. November 2021
​​​​​​​